crohn's glp 1 GLP-1s may reduce steroid dependence in disease, obesity GI and Hepatology News -

Retatrutide is a more recently developed triple agonist peptide, targeting GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors simultaneously

I hope FDA takes this same stance against all illegal compounding and counterfeit products

Nasca's animal studies suggest that acetyl-L-carnitine, a crucial mediator of fat metabolism and energy production throughout the body, plays a special role in the brain, where it works at least in part by preventing the excessive firing of excitatory nerve cells in brain regions called the hippocampus and frontal cortex

These reactions typically manifest as localized skin changes at or near the injection site and are generally mild to moderate in severity